ArticleCureus2026

Effectiveness and Safety of Fixed-Dose Empagliflozin/Linagliptin Combination in Type 2 Diabetes Mellitus: Real-World Evidence From Bangladesh.

Indrajit Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.